Mitch Horowitz, TEConomy Partners LLC. April 2020 2020 Performance Review
Mitch Horowitz, TEConomy Partners LLC.April 2020
2020 Performance Review
What Is Arizona’s Bioscience Roadmap?
• 20-year plan to bring Arizona to competitiveness in Biosciences• Commissioned by the Flinn Foundation, tracked by TEConomy
Partners • Goals: Economic strength and diversity; access to health
innovations for Arizonans• Focus: Leverage research strengths and build critical mass of firms
2
Vision for Arizona in 2025
“Arizona is globally competitive and a national leader in the biosciences in such fields as precision medicine, cancer, neurosciences, bioengineering, diagnostics, and agricultural biotechnology.”
“It excels in offering a deep talent base, a critical mass of entrepreneurs and enterprises, and clinical excellence to turn discovery into firms, products, and talent.”
Source: Second Decade Roadmap, available at www.flinn.org
3
Summary of 2020 Performance Review
• Strong report card—growth found across nearly every performance metric• Both private industry and university research continuing to make
strong strides• Suggests recent renewals of TRIF and Angel Investment Tax Credit
paying off
4
What are the Biosciences?• Agricultural Feedstock & Industrial Biosciences
• Bioscience-Related Distribution
• Drugs, Pharmaceuticals & Diagnostics
• Medical Devices & Equipment
• Research, Testing & Medical Labs
• Hospitals
5
Metric: JobsComposition of Bioscience Jobs in AZ, 2018
Source: TEConomy Partners LLC analysis of Bureau of Labor Statistics, QCEW data from IMPLAN Group LLC
Hospitals, 77%
Non-Hospital Biosciences,
23%
Bioscience-related
Distribution, 34%
Research, Testing, & Medical
Laboratories, 29%
Medical Devices & Equipment,
23%
Drugs & Pharmaceuticals,
11%
Agricultural Feedstock & Industrial Biosciences,
2%
6
Metric: JobsAZ & U.S. Bioscience Employment: 2002-18
Source: TEConomy Partners LLC analysis of Bureau of Labor Statistics, QCEW data from IMPLAN Group LLC
100
110
120
130
140
150
160
170
180
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Grow
th In
dex
(200
2 =
100)
Arizona
U.S.
7
Metric: JobsArizona Employment: 2002-18
Source: TEConomy Partners LLC analysis of Bureau of Labor Statistics, QCEW data from IMPLAN Group LLC
100
110
120
130
140
150
160
170
180
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Grow
th In
dex
(200
2 =
100)
Biosciences
Total Private Sector
8
Metric: JobsEmployment Across Business Cycles
Source: TEConomy Partners LLC analysis of Bureau of Labor Statistics, QCEW data from IMPLAN Group LLC
IndustrySubsector
2002-2007Expansion
2007-2009Recession
2009-2018Recovery/Expansion 2016-2018
AZ U.S. AZ U.S. AZ U.S. AZ U.S.
Total Private Sector 19.8% 5.9% -11.3% -6.2% 22.2% 16.3% 6.2% 3.3%
Total Biosciences 21.6% 8.3% 6.7% 2.5% 32.0% 11.5% 8.3% 3.6%
Total Non-Hospital Biosciences 16.3% 7.5% 5.9% -0.9% 48.5% 17.8% 15.1% 7.2%
9
Metric: JobsArizona Gaining Market Share in Biosciences Industry
Source: TEConomy Partners LLC analysis of Bureau of Labor Statistics, QCEW data from IMPLAN Group LLC
Industry Subsector2002 Arizona Share of U.S.
Total Jobs
2018 Arizona Share of U.S.
Total Jobs
2018 Arizona Specialization Relative to U.S.
(Location Quotient)
Agricultural Feedstock & Industrial Biosciences 0.68% 0.97% 0.50
Bioscience-related Distribution 1.69% 1.86% 0.95
Drugs, Pharmaceuticals & Diagnostics 0.30% 1.05% 0.54
Medical Devices & Equipment 0.87% 1.83% 0.94
Research, Testing, & Medical Laboratories 1.35% 1.51% 0.78
Hospitals 1.39% 1.90% 0.97
Total Non-Hospital Biosciences 1.08% 1.58% 0.81
TOTAL BIOSCIENCES 1.31% 1.81% 0.9310
Metric: WagesBioscience Wages and Growth: 2016-18
Source: TEConomy Partners LLC analysis of Bureau of Labor Statistics, QCEW data from IMPLAN Group LLC
7.0%
8.8%
9.9%
6.9%
7.2%
8.7%
0.0% 5.0% 10.0% 15.0%
Total Private Sector
Total Biosciences
Total Non-HospitalBiosciences
% Change 2016-18
U.S.
Arizona
$51,476
$69,412
$85,518
$0$10,000$20,000$30,000$40,000$50,000$60,000$70,000$80,000$90,000
Total PrivateSector
TotalBiosciences
Total Non-Hospital
Biosciences
AZ Avg. Wages, 2018
11
Flagstaff MSA
• Medical Devices & Equipment;
• Hospitals
Tucson MSA
Phoenix-Mesa-Scottsdale MSA
• Research, Testing & Medical Labs;
• Bioscience-Related Distribution;
• Hospitals; • Drugs &
Pharmaceuticals
• Research, Testing & Medical Labs; • Hospitals;
• Medical Devices & Equipment
Regional Bioscience Industry Strengths
Source: TEConomy Partners LLC analysis of Bureau of Labor Statistics, QCEW data from IMPLAN Group LLC12
Key BioscienceSubsector
Establishments, Employment Level & Concentration (2018)
Regional Strengths/Highlights
Medical Devices & Equipment
Establishments: 3
Employed: 2,763
Employment Growth (02-18): 210.1%
Location Quotient: 19.11
Flagstaff remains highly specialized in medical devices, at more than 19 times the average employment concentration of the nation.
Hospitals
Establishments: 3
Employed: 3,972
Employment Growth (02-18): 60.3%
Location Quotient: 2.04
The hospital subsector is a large employer in Flagstaff, with over 3,900 workers in 2018. It is also growing rapidly, with employment increasing by 60% from 2002-18.
Flagstaff Metro Area
13Source: TEConomy Partners LLC analysis of Bureau of Labor Statistics, QCEW data from IMPLAN Group LLC
Key BioscienceSubsector
Establishments, Employment Level & Concentration (2018)
Regional Strengths/Highlights
Research, Testing & Medical Laboratories
Establishments: 395Employed: 7,141Employment Growth (02-18): 96.7%Location Quotient: 0.85
Employment in research, testing & medical labs over 7,000 in metro Phoenix, with substantial growth of 97% from 2002-18.
Bioscience-related Distribution
Establishments: 1,193Employed: 8,871Employment Growth (02-18): 46.3%Location Quotient: 1.10
Bioscience-related distribution in the Phoenix area is largest non-hospital subsector, 10% more concentrated than national average.
Hospitals
Establishments: 157Employed: 63,241Employment Growth (02-18): 77.0%Location Quotient: 0.84
Hospitals remain the predominant subsector for bioscience employment in metro Phoenix, with 77% growth over 2002-18 period.
Drugs & Pharmaceuticals
Establishments: 65Employed: 3,130Employment Growth (02-18): 239.8%Location Quotient: 0.69
Employment in Drugs & Pharmaceuticals has experienced growth of 240% from 2002-18 in Phoenix, though it is still significantly less concentrated than the national average. Nearly all state gains are found in Phoenix in recent years.
Phoenix-Mesa-Scottsdale Metro Area
14Source: TEConomy Partners LLC analysis of Bureau of Labor Statistics, QCEW data from IMPLAN Group LLC
Key BioscienceSubsector
Establishments, Employment Level & Concentration (2018)
Regional Strengths/Highlights
Research, Testing & Medical Laboratories
Establishments: 101Employed: 1,054Employment Growth (02-18): 30.6%Location Quotient: 0.77
The research, testing & medical labs subsector in the Tucson area increased employment by 31% over the 2002-18 period.
Hospitals
Establishments: 18Employed: 16,741Employment Growth (02-18): 34.7%Location Quotient: 1.36
Tucson has a large, growing, and specialized hospital subsector with 36% higher employment concentration than the national average.
Medical Devices & Equipment
Establishments: 19Employed: 715Employment Growth (02-18): 24.3%Location Quotient: 0.78
Tucson's medical devices & equipment subsector grew by 24% over the 2002-18 period, but is 22% less concentrated than the national average.
Tucson Metro Area
15Source: TEConomy Partners LLC analysis of Bureau of Labor Statistics, QCEW data from IMPLAN Group LLC
Key Innovation Ecosystem Driving Bio Industry
16
Metric: Bioscience R&DAZ & U.S. Bioscience Academic R&D: 2002-18
Source: NSF Academic S&E R&D Expenditures and TEConomy Partners calculations
100
120
140
160
180
200
220
240
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Grow
th In
dex
(200
2 =
100)
U.S.
Arizona
17
Metric: Bioscience R&DArizona Universities
University of Arizona
67%
Arizona State University
27%
Northern Arizona University6%
Percent Change in Total Bioscience R&D by University Bioscience R&D Expenditures by University, 2018
Source: NSF Academic S&E R&D Expenditures and TEConomy Partners calculations
12%
23%
25%
34%
8%
14%
4%
28%
0% 10% 20% 30% 40%
U.S.
University of Arizona
Arizona State University
Northern Arizona University
2014-16
2016-18
18
Metric: NIHAZ & U.S. NIH Funding: 2002-19
Source: NIH RePORT database, and TEConomy Partners calculations
100
110
120
130
140
150
160
170
180
190
200
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Grow
th In
dex
(200
2 =
100)
U.S.
Arizona
19
Metric: NIHArizona Share of NIH Support
Source: NIH RePORT database, and TEConomy Partners calculations
0.87% 0.87%
0.79% 0.80% 0.79% 0.77%0.72%
0.77%
0.86% 0.88%
0.76%0.71% 0.73%
0.81%
0.71%0.65% 0.66%
0.72%
0.84% 0.84%
0.00%
0.10%
0.20%
0.30%
0.40%
0.50%
0.60%
0.70%
0.80%
0.90%
1.00%
2002 2006 2012 2013 2014 2015 2016 2017 2018 2019
Awards Funding
20
Metric: NIHAZ NIH Funding Distribution: FY 2019
Source: NIH RePORT database, and TEConomy Partners calculations
Arizona Public Universities
$214,357,712
Arizona Hospitals and Other Research
Institutions$31,567,514
Arizona Bioscience Companies
$17,036,510
21
Source: Arizona university technology transfer offices
Key Bioscience Tech-Transfer Metrics
Total Bio2018-2019
Growth2016-17 to
2018-19
Bio Share of Tech Transfer2018-19
Invention Disclosures Received 531 -9% 43%
Total U.S. Patent Applications Filed 623 9% 53%
U.S. Patents Issued 180 51% 48%
Licenses & Options Executed 129 -2% 35%
Adjusted Gross License Income Received $8.7 m -36% 75%
Bioscience Startups from University IP 32 -3% 52%
Metric: Technology Transfer
22
Metric: Venture CapitalAZ & U.S. Bio Venture Capital: 2002-19
Source: PitchBook Data with TEConomy Partners Calculations
$B
$5B
$10B
$15B
$20B
$25B
$30B
$35B
$0M
$50M
$100M
$150M
$200M
$250M
$300M
$350M
2002 2006 2012 2013 2014 2015 2016 2017 2018 2019
U.S.
Bio
scie
nce-
rela
ted
VC In
vest
men
ts
Arizo
na B
iosc
ienc
e-re
late
d VC
In
vest
men
ts
Arizona
U.S.
23
Metric: Venture CapitalPerspective on Venture Capital:
Source: PitchBook Data with TEConomy Partners Calculations
State Amount of bioscience venture capital per $1 in NIH funding, 2019
Texas $0.66Florida $0.68Arizona $0.75U.S. Average $1.02Massachusetts $1.93California $2.62
24
Metric: Venture CapitalAZ & U.S. Venture Capital Deals by Stage, 2016-19
Source: PitchBook Data with TEConomy Partners Calculations
9.6%19.4%
19.1%
27.2%8.3%
12.6%34.4%
16.9%
28.7% 23.9%
0%10%20%30%40%50%60%70%80%90%
100%
Arizona U.S.
Deals
Pre-Seed
Angel
Seed
Early stage VC
Later stage VC
25
Metric: Venture CapitalShare of VC Investments by Bio-Related Industry, 2016-19
Source: PitchBook Data with TEConomy Partners Calculations
Arizona U.S.
Bioscience IT, 32%
Medical Devices,
32%
Pharmaceuticals, 21%
Biotech, 6%
Healthcare Services, 5%
Other Healthcare, 4%
Bioscience IT, 24%
Medical Devices,
18%
Pharmaceuticals, 21%
Biotech, 31%
Healthcare Services, 4%
Other Healthcare, 3%
26
Summary of Bioscience Industry Metrics of Success:
Metrics Performance Details
Bio Industry Sector Job Growth
• 8.3% Bio growth in AZ from 2016-2018• More than 2x U.S. growth of 3.6%• Outpacing all private sector job growth
in AZ of 6.2% from 2016-2018• Generally strong growth across Bio
industry sub-sectors in Arizona
Bio Average Wages
• 8.8% Bio growth in AZ from 2016-2018 – higher than U.S. Bio growth of 7.2%
• At $69k for total Bio, 35% higher than average for all private sector jobs
• Even higher metrics for Bio non-hospital: $86k, 9.9% growth
27
Summary of Bio Innovation Ecosystem Metrics of Success:Metrics Performance Details
University Bio R&D Funding
• All AZ research universities growing faster from 2016-18 than 2014-16 periods
• 25% growth outpaced national growth of 12%
NIH Funding • Major upswing since 2015• AZ highest level of US share since started tracking back in 2002
Bio University IP
• Strong gains in patents issued and applications• Startups and licenses on par with prior years• Disclosures down slightly and license income declined more
substantially
Bio Risk Capital
• Strong rebound in Bio Risk funding in 2019• Arizona now above Florida and Texas in bio risk capital per NIH
funding• Share of early stage Bio deals above US and 2002-2019 average
for Arizona28
Contact TEConomy Partners
Mitch HorowitzPrincipal and Managing DirectorTEConomy Partners, LLC(240) [email protected]
29